[Skip to Content]
[Skip to Content Landing]
Other Articles
October 13, 1951

AMINOPHYLLINE AS SUPPLEMENT TO MERCURIAL DIURETICS IN INTRACTABLE CONGESTIVE HEART FAILURE

Author Affiliations

New York

From the Third Medical (New York University) Division, Bellevue Hospital.; Assistant Professor of Clinical Medicine, New York University College of Medicine and Associate Visiting Physician, Bellevue Hospital (Dr. Vogl); Resident in Medicine, Bellevue Hospital (Dr. Esserman).

JAMA. 1951;147(7):625-630. doi:10.1001/jama.1951.03670240009003
Abstract

Management of the persistently edematous patient in an advanced stage of congestive heart failure presents a serious problem frequently encountered in medical practice. Such a patient is commonly considered refractory to treatment when he no longer responds to the combined use of bed rest, low salt diet, adequate digitalization and repeated mercurial injections. In particular, the lack of an adequate response to mercurial diuretics is generally regarded as an ominous sign,1 indicating that the terminal stage of heart failure has been reached. Since all other measures are generally regarded as auxiliary to digitalis therapy, the most rigid criteria of full digitalization must be fulfilled before a therapeutic regimen can be called a failure.

Whenever it can be established that inadequate digitalization is not at fault, different therapeutic approaches must be considered. There are on record cases in which serum sodium reached abnormally low levels as a result of repeated

First Page Preview View Large
First page PDF preview
First page PDF preview
×